NL-OMON20351已完成不适用
A randomised phase III study on the treatment of children and adolescents with refractory or relapsed acute myeloid leukemia (AML).
Dutch Childhood Oncology GroupDen HaagThe Netherlands0 个研究点目标入组 400 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 400
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Primary refractory AML;
排除标准
- •1. Symptomatic cardiac dysfunction (CTC grade 3 or 4), and/or a fractional shortening at echocardiography below 29%;
研究者
相似试验
招募中
不适用
OROCSON study: Late Onset Recurrent Ovarian Cancer: Surgery Or Not.NL-OMON27781700
已完成
不适用
A randomized phase III study on the effect of the chimeric anti-CD20 monoclonal antibody (MabThera) during sequential chemotherapy followed by autologous stem cell transplantation in patients with relapsed or progressive B-cell non-Hodgkin’s lymphoma.on Hodgkin’s LymphomaNL-OMON29096Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON) P/a HOVON Data CenterErasmus MC - Daniel den HoedPostbus 52013008 AE RotterdamTel: 010 4391568Fax: 010 4391028e-mail: hdc@erasmusmc.nl300
尚未招募
不适用
A randomized phase III study in previously untreated patients with biological high-risk CLL: Fludarabine + cyclophosphamide (FC) versus FC + low-dose alemtuzumab.Chronic Lymphocytic LeukemiaNL-OMON25345Dr. C.H. GeislerRigshospitaletDept. of Hematology (L 4042)Blegdamsvej 9DK-2100 CopenhagenDenmarkTel: 0045 35451146Fax: 0045 35454283e-mail:geisler@rh.dk300
招募中
1 期
A randomised controlled trial of a simplified management strategy in OSARespiratory - Sleep apnoeaOSAACTRN12605000064606HMRC240
已完成
2 期
Safety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's DiseaseAlzheimer's DiseaseNCT00359944Sumitomo Pharma America, Inc.171